Pharmacology of Parkinson's disease Flashcards
What is the mainstay of treatment for Parkinson’s disease? (Pharm)
State the trade name, ingredients, and the dosage.
L-DOPA and carbidopa, dose 500 to 1500 mg L-DOPA with 250 mg Carbidopa/day
L-DOPA remains by far the most important drug for treating Parkinson’s disease. Combined with the peripheral decarboxylase inhibitor carbidopa as Sinemet, L-DOPA provides useful clinical benefit for 5 to 20 years after diagnosis.
Name 2 dopamine receptor agonists.
Pramipexole
Ropinirole
[Bromocriptine]
Largely D2 agonists.
Name a drug that facilitates release of endogenous dopamine.
Amantadine
Also produces an NMDA block, presumably by acting as a glutamate antagonist.
[notes explicitly state “glutamate antagonist]
Name 3 anticholinergic drugs used in the treatment of Parkinson’s.
- Trihexyphenidyl
- Benzotropine
- Diphenhydramine
**Less used to to sfx
Name a MAO inhibitor used in the treatment of Parkinsons’s.
Selegiline.
Name 2 COMT inhibitors used in the treatment of Parkinson’s.
What does COMT stand for?
Entacapone
[Tolcapone]
Catechol-o-methyl transferase
Pramipexole
Dopamine receptor agonist.
Ropinirole
Dopamine receptor agonist.
Amantadine
Endogenous dopamine release, NMDA block
Trihexyphenidyl
Anticholinergic
Benztropine
Anticholinergic
Diphenhydramine
Anticholinergic
Selegiline
MAO-B inhibitor
Tolcapone
COMT inhibitor.
Entacapone
COMT inhibitor.